Dabigatran
What is Dabigatran?
Dabigatran (CAS 211914-51-1), also referenced under the development code BIBR-953, is a direct thrombin inhibitor used as an active pharmaceutical ingredient in anticoagulant drug development.
Where is Dabigatran used?
- Oral anticoagulant formulations: pharmacologically active moiety targeting thromboembolic conditions
- Finished dosage form development for stroke prevention and venous thromboembolism treatment, typically formulated as the etexilate prodrug salt for oral bioavailability
- Reference standard or synthetic intermediate in API characterization, method validation, and quality control workflows
- Pharmacokinetic studies in research institutions and contract development organizations
- It serves as a benchmark compound in assay development for thrombin inhibition screening programs.
Commercial specifications
- Purity grades aligned with reference standard requirements
- Packaging from milligram quantities for laboratory use to larger quantities supporting API development pipelines
Other Names (Synonyms)
Pradaxa|BIBR-953|Pradaxa (dabigatran)|BIBR 953 ZW|I0VM4M70GC